February 1, 2022 | Targeted Therapies in Oncology

Novel ER Approaches for HR+/HER2– Breast Cancer Are Explored During SABCS

January 31, 2022

Clinical Articles

Research is ongoing to combat key resistance mechanisms, with new data recently presented by Sara A. Hurvitz, MD, FACP, and other oncologists and investigators during the 2021 San Antonio Breast Cancer Symposium.